Article Text

Download PDFPDF
Therapeutic drug monitoring of vancomycin in the case of augmented renal clearance: a case report of a paediatric patient
  1. Hasan Memiş1,
  2. Ahmet Çakır1,
  3. Ayşe Ülgey2
  1. 1Clinical Pharmacy, Inonu University Faculty of Pharmacy, Malatya, Türkiye
  2. 2Anaesthesiology and Reanimation, Erciyes University Faculty of Medicine, Kayseri, Türkiye
  1. Correspondence to Dr Ahmet Çakır, Clinical Pharmacy, Inonu University, Malatya 44000, Turkey; eczahmetcakir{at}hotmail.com

Abstract

Augmented renal clearance (ARC) is a condition in which renal circulation increases, causing drug levels in the blood to remain at subtherapeutic levels in severe trauma patients. Vancomycin, a hydrophilic anti-Gram-positive drug, has been shown in the literature to have its levels fall below the therapeutic range in the case of ARC. However, vancomycin dosing recommendations in the case of ARC are still lacking. Here, we identify an ARC case measured with urinary creatinine clearance in a severe trauma paediatric patient, causing vancomycin blood trough levels to drop. We could not be able to increase the vancomycin trough levels with intermittent dosing; hence, we administered vancomycin with continuous infusion, and this resulted in vancomycin blood trough levels remaining in the therapeutic range. No adverse effect was seen. Continuous infusion of vancomycin can be safely administered to paediatric patients in these cases.

  • PHARMACY SERVICE, HOSPITAL
  • Drug Monitoring
  • Critical Care
  • Case Reports
  • PEDIATRICS

Data availability statement

All data relevant to the study are included in the article.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article.

View Full Text